renaiss health limited
renaiss health limited Company Information
Company Number
13732293
Next Accounts
Dec 2025
Directors
Shareholders
bridges healthcare holdings (uk) limited
Group Structure
View All
Industry
Other human health activities
Registered Address
156 blackfriars road, london, SE1 8EN
Website
renaisshealth.comrenaiss health limited Estimated Valuation
Pomanda estimates the enterprise value of RENAISS HEALTH LIMITED at £128.9k based on a Turnover of £242.8k and 0.53x industry multiple (adjusted for size and gross margin).
renaiss health limited Estimated Valuation
Pomanda estimates the enterprise value of RENAISS HEALTH LIMITED at £0 based on an EBITDA of £-1.1m and a 3.92x industry multiple (adjusted for size and gross margin).
renaiss health limited Estimated Valuation
Pomanda estimates the enterprise value of RENAISS HEALTH LIMITED at £0 based on Net Assets of £-2.6m and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Renaiss Health Limited Overview
Renaiss Health Limited is a live company located in london, SE1 8EN with a Companies House number of 13732293. It operates in the other human health activities sector, SIC Code 86900. Founded in November 2021, it's largest shareholder is bridges healthcare holdings (uk) limited with a 100% stake. Renaiss Health Limited is a startup, micro sized company, Pomanda has estimated its turnover at £242.8k with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Renaiss Health Limited Health Check
Pomanda's financial health check has awarded Renaiss Health Limited a 0.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 7 areas for improvement. Company Health Check FAQs
0 Strong
2 Regular
7 Weak
Size
annual sales of £242.8k, make it smaller than the average company (£727.5k)
- Renaiss Health Limited
£727.5k - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Renaiss Health Limited
- - Industry AVG
Production
with a gross margin of 38.6%, this company has a comparable cost of product (38.6%)
- Renaiss Health Limited
38.6% - Industry AVG
Profitability
an operating margin of -466.6% make it less profitable than the average company (5%)
- Renaiss Health Limited
5% - Industry AVG
Employees
with 7 employees, this is below the industry average (19)
7 - Renaiss Health Limited
19 - Industry AVG
Pay Structure
on an average salary of £26.5k, the company has an equivalent pay structure (£26.5k)
- Renaiss Health Limited
£26.5k - Industry AVG
Efficiency
resulting in sales per employee of £34.7k, this is less efficient (£45.5k)
- Renaiss Health Limited
£45.5k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Renaiss Health Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 10 days, this is quicker than average (18 days)
- Renaiss Health Limited
18 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Renaiss Health Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (127 weeks)
0 weeks - Renaiss Health Limited
127 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 5620.8%, this is a higher level of debt than the average (22.3%)
5620.8% - Renaiss Health Limited
22.3% - Industry AVG
RENAISS HEALTH LIMITED financials
Renaiss Health Limited's latest turnover from March 2024 is estimated at £242.8 thousand and the company has net assets of -£2.6 million. According to their latest financial statements, Renaiss Health Limited has 7 employees and maintains cash reserves of £6 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | |
|---|---|---|
| Turnover | ||
| Other Income Or Grants | ||
| Cost Of Sales | ||
| Gross Profit | ||
| Admin Expenses | ||
| Operating Profit | ||
| Interest Payable | ||
| Interest Receivable | ||
| Pre-Tax Profit | ||
| Tax | ||
| Profit After Tax | ||
| Dividends Paid | ||
| Retained Profit | ||
| Employee Costs | ||
| Number Of Employees | 7 | 3 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | |
|---|---|---|
| Tangible Assets | 3,680 | |
| Intangible Assets | 18,814 | |
| Investments & Other | ||
| Debtors (Due After 1 year) | ||
| Total Fixed Assets | 22,494 | |
| Stock & work in progress | ||
| Trade Debtors | ||
| Group Debtors | 11,487 | |
| Misc Debtors | 12,734 | 85,039 |
| Cash | 6 | |
| misc current assets | ||
| total current assets | 24,227 | 85,039 |
| total assets | 46,721 | 85,039 |
| Bank overdraft | ||
| Bank loan | ||
| Trade Creditors | 4,493 | |
| Group/Directors Accounts | ||
| other short term finances | 2,466,271 | 1,188,631 |
| hp & lease commitments | ||
| other current liabilities | 155,317 | 137,352 |
| total current liabilities | 2,626,081 | 1,325,983 |
| loans | ||
| hp & lease commitments | ||
| Accruals and Deferred Income | ||
| other liabilities | ||
| provisions | ||
| total long term liabilities | ||
| total liabilities | 2,626,081 | 1,325,983 |
| net assets | -2,579,360 | -1,240,944 |
| total shareholders funds | -2,579,360 | -1,240,944 |
| Mar 2024 | Mar 2023 | |
|---|---|---|
| Operating Activities | ||
| Operating Profit | ||
| Depreciation | 1,159 | |
| Amortisation | ||
| Tax | ||
| Stock | ||
| Debtors | -60,818 | 85,039 |
| Creditors | 4,493 | |
| Accruals and Deferred Income | 17,965 | 137,352 |
| Deferred Taxes & Provisions | ||
| Cash flow from operations | ||
| Investing Activities | ||
| capital expenditure | ||
| Change in Investments | ||
| cash flow from investments | ||
| Financing Activities | ||
| Bank loans | ||
| Group/Directors Accounts | ||
| Other Short Term Loans | 1,277,640 | 1,188,631 |
| Long term loans | ||
| Hire Purchase and Lease Commitments | ||
| other long term liabilities | ||
| share issue | ||
| interest | ||
| cash flow from financing | ||
| cash and cash equivalents | ||
| cash | 6 | |
| overdraft | ||
| change in cash | 6 |
renaiss health limited Credit Report and Business Information
Renaiss Health Limited Competitor Analysis
Perform a competitor analysis for renaiss health limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in SE1 area or any other competitors across 12 key performance metrics.
renaiss health limited Ownership
RENAISS HEALTH LIMITED group structure
Renaiss Health Limited has no subsidiary companies.
Ultimate parent company
1 parent
RENAISS HEALTH LIMITED
13732293
renaiss health limited directors
Renaiss Health Limited currently has 1 director, Mr Simon Ringer serving since Nov 2021.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Simon Ringer | England | 60 years | Nov 2021 | - | Director |
P&L
March 2024turnover
242.8k
+82%
operating profit
-1.1m
0%
gross margin
38.6%
+2.83%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
-2.6m
+1.08%
total assets
46.7k
-0.45%
cash
6
0%
net assets
Total assets minus all liabilities
Similar Companies
renaiss health limited company details
company number
13732293
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
November 2021
age
4
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
March 2024
previous names
healthcare opco (uk) limited (January 2023)
accountant
-
auditor
COOPER PARRY GROUP LIMITED
address
156 blackfriars road, london, SE1 8EN
Bank
-
Legal Advisor
-
renaiss health limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to renaiss health limited. Currently there are 1 open charges and 0 have been satisfied in the past.
renaiss health limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for RENAISS HEALTH LIMITED. This can take several minutes, an email will notify you when this has completed.
renaiss health limited Companies House Filings - See Documents
| date | description | view/download |
|---|
